A 56-year-old man presents with severe right-sided otalgia, right-sided facial droop, dysgeusia, and vertigo. Examination reveals vesicular eruption in the right concha, external auditory canal, and soft palate, with lower motor neuron facial palsy (House-Brackmann V). Tuning fork tests show Weber lateralizing to the left, indicating right-sided sensorineural hearing loss. The structure marked **A** in the diagram represents this constellation of findings. Which of the following is the MOST appropriate management for this patient?
A. High-dose acyclovir 800 mg 5 times daily for 7–10 days plus oral prednisolone 60–80 mg/day with taper, initiated within 72 hours
B. Watchful waiting with analgesics only, reserving antivirals for immunocompromised patients
C. Oral amoxicillin-clavulanate for 10 days with topical corticosteroid drops, as bacterial superinfection is the primary concern
D. Topical antibiotic drops and observation, as vesicles are self-limiting and hearing recovers spontaneously in most cases
Explanation
Why option 1 is correct
The clinical presentation—vesicular eruption in the concha, EAC, and soft palate combined with ipsilateral peripheral facial paralysis and sensorineural hearing loss—is pathognomonic for Ramsay Hunt syndrome (herpes zoster oticus), caused by reactivation of varicella-zoster virus in the geniculate ganglion of the facial nerve. The structure marked A explicitly encompasses this triad: SNHL with vesicular eruption and facial palsy managed with antivirals and steroids. According to Dhingra ENT 7e and Sweeney (Lancet ID 2001), prompt high-dose acyclovir (800 mg 5 times daily) or valacyclovir (1 g TID) for 7–10 days COMBINED with oral corticosteroids (prednisolone 60–80 mg/day with taper) must be initiated within 72 hours of symptom onset to maximize recovery of facial function and minimize hearing loss. This dual therapy addresses both the viral replication and the inflammatory component of the disease.
Why each distractor is wrong
Option 2: Topical drops alone are insufficient for Ramsay Hunt syndrome. This approach ignores the systemic viral infection of the geniculate ganglion and cochleovestibular nerve complex. Vesicles are NOT self-limiting without antiviral therapy, and sensorineural hearing loss is permanent without prompt intervention. This management would be appropriate only for conductive hearing loss or isolated Bell palsy without vesicles (structure B or C).
Option 3: Bacterial superinfection is not the primary pathophysiology of Ramsay Hunt syndrome; the disease is caused by VZV reactivation, not bacterial infection. Amoxicillin-clavulanate is ineffective against herpes zoster and delays critical antiviral therapy. Topical corticosteroid drops do not address systemic viral replication or the need for high-dose systemic corticosteroids.
Option 4: Watchful waiting with analgesics only is contraindicated. Unlike Bell palsy (which has 70%+ full recovery), Ramsay Hunt syndrome has only ~50% full recovery of facial function and carries high risk of permanent SNHL and postherpetic neuralgia. The time-sensitive window (<72 hours) for antiviral initiation is critical and well-established in the literature.
High-YieldNEET PG
Ramsay Hunt = vesicles + facial palsy + SNHL/vertigo = prompt antivirals + steroids within 72 hours; prognosis worse than Bell palsy (50% vs 70%+ full recovery).
Dhingra ENT 7e Ch 17; Sweeney Ramsay Hunt Lancet ID 2001
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
